Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CELL THERAPY INDUSTRY
2.1 Summary about Cell Therapy Industry
2.2 Cell Therapy Market Trends
2.2.1 Cell Therapy Production & Consumption Trends
2.2.2 Cell Therapy Demand Structure Trends
2.3 Cell Therapy Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Nanotechnology
4.2.2 Natural Substances
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Scientific Research
4.3.2 Hospital
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Nanotechnology
5.2.2 Natural Substances
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Scientific Research
5.3.2 Hospital
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Nanotechnology
6.2.2 Natural Substances
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Scientific Research
6.3.2 Hospital
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Nanotechnology
7.2.2 Natural Substances
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Scientific Research
7.3.2 Hospital
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Nanotechnology
8.2.2 Natural Substances
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Scientific Research
8.3.2 Hospital
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Nanotechnology
9.2.2 Natural Substances
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Scientific Research
9.3.2 Hospital
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Dendreon
10.1.2 Mesoblast
10.1.3 Vericel
10.1.4 AlloCure
10.1.5 Amorcyte
10.1.6 Anterogen
10.1.7 Antibe Therapeutics
10.1.8 Astellas Pharma
10.1.9 Athersys
10.1.10 Avita Medical
10.1.11 AxoGen
10.1.12 Bellicum Pharmaceuticals
10.1.13 BioCardia
10.1.14 BIOCELLULAR THERAPIES
10.1.15 Biogen Idec
10.1.16 Bio-Tissue
10.1.17 BIOTIME
10.1.18 BioTissue Technologies
10.1.19 BrainStorm Cell Therapeutics
10.1.20 Bluebird Bio
10.1.21 Bone Therapeutics
10.1.22 Caladrius
10.1.23 Capricor Therapeutics
10.1.24 CellBioMed
10.1.25 Celgene
10.1.26 Cell Medica
10.2 Cell Therapy Sales Date of Major Players (2017-2020e)
10.2.1 Dendreon
10.2.2 Mesoblast
10.2.3 Vericel
10.2.4 AlloCure
10.2.5 Amorcyte
10.2.6 Anterogen
10.2.7 Antibe Therapeutics
10.2.8 Astellas Pharma
10.2.9 Athersys
10.2.10 Avita Medical
10.2.11 AxoGen
10.2.12 Bellicum Pharmaceuticals
10.2.13 BioCardia
10.2.14 BIOCELLULAR THERAPIES
10.2.15 Biogen Idec
10.2.16 Bio-Tissue
10.2.17 BIOTIME
10.2.18 BioTissue Technologies
10.2.19 BrainStorm Cell Therapeutics
10.2.20 Bluebird Bio
10.2.21 Bone Therapeutics
10.2.22 Caladrius
10.2.23 Capricor Therapeutics
10.2.24 CellBioMed
10.2.25 Celgene
10.2.26 Cell Medica
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
